White Papers

Abstract: Digital Pathology – The Future Is Here

Digital pathology is transforming how clinical laboratories and pathology practices manage diagnostic workflows, collaborate across locations, and deliver timely patient care. Although whole slide imaging (WSI) technology has existed for decades, its widespread adoption has historically been slowed by regulatory restrictions, reimbursement pressures, infrastructure costs, and limited investment. However, growing pathology workloads, workforce shortages, and the need for greater operational efficiency have accelerated the industry's transition toward digital diagnostics.

This white paper examines the evolution of digital pathology, the challenges affecting its adoption, and the opportunities created by integrating digital imaging technology with advanced laboratory information systems (LIS).

Featuring insights from LigoLab CEO Suren Avunjian and Chief Technology Officer Anthony (Tony) Oganesian, the paper highlights how the COVID-19 pandemic became a turning point for digital pathology. Temporary regulatory flexibility from the FDA and CMS enabled pathologists to review cases remotely, demonstrating the potential of digital workflows to improve accessibility, collaboration, and continuity of patient care.

Central to the discussion is the importance of interoperability. A successful digital pathology ecosystem requires seamless connectivity between whole slide scanners, image management systems, digital viewers, and laboratory information systems.

The white paper explores how LigoLab's unified LIS and revenue cycle management (RCM) platform provides the foundation for integrated digital pathology workflows through its proprietary interface engine and extensive connectivity capabilities.

Using a real-world integration with the Philips Image Management System (IMS), the paper demonstrates how LigoLab supports contextual viewer launches, coordinated case management, voice-to-text documentation, image capture, and customized pathology reporting.

Beyond workflow improvements, digital pathology enables more efficient case distribution, remote collaboration, simplified image archiving, and greater scalability across pathology networks.

Ultimately, this white paper demonstrates that digital pathology is more than a technological advancement. It represents a fundamental transformation in how pathology services are delivered. By combining advanced imaging technology with a highly configurable, interoperable LIS platform, laboratories can improve diagnostic efficiency, overcome geographic limitations, and establish a scalable foundation for future innovation.

Key Takeaways

1. Digital pathology represents a major advancement in laboratory medicine. 

2. Regulatory barriers historically slowed digital pathology adoption. 

3. The FDA's 2017 authorization marked a significant milestone. 

4. The COVID-19 pandemic accelerated digital pathology innovation. 

5. Remote pathology review improves accessibility and collaboration. 

6. Interoperability is essential to successful digital pathology implementation.

7. A modern LIS serves as the foundation of the digital pathology ecosystem. 

8. LigoLab's proprietary interface engine supports extensive connectivity. 

9. Integrated digital pathology workflows reduce unnecessary system navigation. 

10. Digital pathology enhances diagnostic documentation and reporting. 

11. Digital slide archives improve accessibility and efficiency. 

12. Advanced imaging technology supports higher-volume pathology operations.

13. Digital case distribution strengthens pathology network performance.

14. Digital pathology helps address workforce challenges. 

15. LigoLab provides an adaptable foundation for digital pathology growth.

16. Digital transformation creates opportunities for better patient care.